Voyager Therapeutics Inc (VYGR)
5.73
-0.19
(-3.21%)
USD |
NASDAQ |
Jan 08, 16:00
5.74
+0.01
(+0.17%)
After-Hours: 20:00
Voyager Therapeutics SG&A Expense (Quarterly): 8.168M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 128.20M |
| Rhythm Pharmaceuticals Inc | 35.38M |
| NovaBay Pharmaceuticals Inc | 2.65M |
| Palatin Technologies Inc | 2.021M |
| iBio Inc | 2.801M |